Preoperative CA19-9 Levels and Lymph Node Ratio Are Independent Predictors of Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma
R A Smith(American Cancer Society), John P. Neoptolemos(University of Liverpool), Michael Raraty(University of Liverpool), Robert Sutton(University of Liverpool), Fiona Campbell(University of Birmingham), L. Bosonnet, Paula Ghaneh(University of Liverpool)
Cited by 79
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k